elafibranor, Placebo of Elafibranor, elafibranor
CLIN-60190-453
Phase 2 small_molecule active
Quick answer
elafibranor, Placebo of Elafibranor, elafibranor for Primary Sclerosing Cholangitis is a Phase 2 program (small_molecule) at Ipsen Pharma with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Ipsen Pharma
- Indication
- Primary Sclerosing Cholangitis
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active